BIODESIX INC (BDSX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$23.27M | +52.2% |
| 2024 | -$48.65M | -112.7% |
| 2023 | -$22.87M | +49.1% |
| 2022 | -$44.97M | -59.3% |
| 2021 | -$28.22M | -32.1% |
| 2020 | -$21.37M | +1.7% |
| 2019 | -$21.73M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$23.27M | +52.2% |
| 2024 | -$48.65M | -112.7% |
| 2023 | -$22.87M | +49.1% |
| 2022 | -$44.97M | -59.3% |
| 2021 | -$28.22M | -32.1% |
| 2020 | -$21.37M | +1.7% |
| 2019 | -$21.73M | — |